Literature DB >> 10458756

Induction of inhibitory antibodies to the CCR5 chemokine receptor and their complementary role in preventing SIV infection in macaques.

T Lehner1, Y Wang, C Doyle, L Tao, L A Bergmeier, E Mitchell, W M Bogers, J Heeney, C G Kelly.   

Abstract

The seven-transmembrane G-protein-linked CCR5 molecule functions as a major coreceptor for HIV or simian immunodeficiency virus (SIV) infection. Antibodies to CCR5 were studied in rhesus macaques immunized with SIV grown in human CD4(+) T cells. These macaques were completely protected against i.v. challenge with live SIV. Sera from the protected macaques showed significantly greater inhibition of SIV replication (p < 0.001) and macrophage inflammatory protein-1beta-generated CCR5-dependent chemotaxis (p < 0.01) than sera from unprotected macaques, in the absence of significant neutralizing antibodies to SIV. These two functional assays demonstrate serum antibodies to the CCR5 receptors which were specifically inhibited by CCR5-transfected HEK-293 cells. We postulate that anti-CCR5 antibodies may be complementary to beta-chemokines in blocking CCR5 coreceptors to HIV or SIV binding and fusion of CD4(+) cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458756     DOI: 10.1002/(SICI)1521-4141(199908)29:08<2427::AID-IMMU2427>3.0.CO;2-5

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

1.  Inhibition of human immunodeficiency virus type 1 infection of human CD4+ T cells by microbial HSP70 and the peptide epitope 407-426.

Authors:  Kaboutar Babaahmady; Wulf Oehlmann; Mahavir Singh; Thomas Lehner
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

2.  Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophages.

Authors:  K Mori; M Rosenzweig; R C Desrosiers
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

3.  Allo-immunization elicits CCR5 antibodies, SDF-1 chemokines, and CD8-suppressor factors that inhibit transmission of R5 and X4 HIV-1 in women.

Authors:  Y Wang; J Underwood; R Vaughan; A Harmer; C Doyle; T Lehner
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

4.  Alloantigen-based AIDS vaccine: revisiting a "rightfully" discarded promising strategy.

Authors:  Gene M Shearer; Adriano Boasso
Journal:  F1000 Med Rep       Date:  2011-06-01

Review 5.  Development of a human leukocyte antigen-based HIV vaccine.

Authors:  Yufei Wang
Journal:  F1000Res       Date:  2018-06-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.